Filing Details
- Accession Number:
- 0001209191-14-009116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-11 16:23:55
- Reporting Period:
- 2014-02-10
- Filing Date:
- 2014-02-11
- Accepted Time:
- 2014-02-11 16:23:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1571498 | Epizyme Inc. | EPZM | Pharmaceutical Preparations (2834) | 261349956 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 816284 | Celgene Corp /De/ | 86 Morris Avenue Summit NJ 07901 | No | No | Yes | No | |
| 1577650 | Celgene European Investment Co Llc | 86 Morris Avenue Summit NJ 07901 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-10 | 340,000 | $29.25 | 3,674,640 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Of these shares, 3,607,974 are owned directly by Celgene European Investment Company LLC ("CEICO"), a wholly-owned subsidiary of Celgene Corporation ("Celgene"), and Celgene has the power to vote, acquire, hold and dispose of all such shares. Celgene disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. The remaining 66,666 shares are owned directly by Celgene Corporation. CEICO disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Billionaire Hedge Funds
